BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Hepatitis
,
Intestine
,
Laser capture microdissection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
neurotensin cells
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Construction of recombinant HEK293 cell lines for the expression of the neurotensin receptor NTSR1.
Synthetic neurotensin analogues are nontoxic analgesics for the rabbit cornea.
Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor r…
MiRNA mimic screen for improved expression of functional neurotensin receptor from HEK293 cells.
Neurotensin-Conjugated Reduced Graphene Oxide with Multi-Stage Near-Infrared-Triggered Synergic Targ…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung Adenocarcino…
A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate Cancer
Phase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial …
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With…
Tissue Predictors of Abiraterone Benefit
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ